News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,869 Results
Type
Article (14268)
Company Profile (105)
Press Release (259488)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88280)
Career Advice (465)
Deals (15393)
Drug Delivery (73)
Drug Development (36727)
Employer Resources (50)
FDA (6383)
Job Trends (6232)
News (150723)
Policy (14131)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (444)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23319)
ALS (56)
Alzheimer's disease (478)
Antibody-drug conjugate (ADC) (99)
Approvals (6574)
Artificial intelligence (201)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1317)
Cardiovascular disease (151)
Career advice (418)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32023)
Collaboration (725)
Compensation (325)
Complete response letters (33)
COVID-19 (783)
CRISPR (43)
C-suite (433)
Cystic fibrosis (58)
Data (1821)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1382)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33461)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (38988)
Executive appointments (528)
FDA (7481)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (428)
Gene editing (70)
Generative AI (18)
Gene therapy (165)
GLP-1 (439)
Government (1405)
Grass and pollen (4)
Guidances (164)
Healthcare (3577)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (847)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (114)
Interviews (60)
IPO (5913)
IRA (33)
Job creations (2055)
Job search strategy (374)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3448)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1304)
Medtech (1311)
Mergers & acquisitions (9900)
Metabolic disorders (434)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (37)
Neuroscience (887)
Neurotech (1)
NextGen: Class of 2026 (1590)
Non-profit (600)
Now hiring (17)
Obesity (227)
Opinion (141)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (222)
Patient recruitment (116)
Peanut (12)
People (29748)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8306)
Phase 2 (13520)
Phase 3 (12213)
Pipeline (1904)
Policy (135)
Postmarket research (1401)
Preclinical (3342)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (350)
Real estate (2659)
Recruiting (18)
Regulatory (10956)
Reports (15)
Research institute (574)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (80)
Series B (48)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1644)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (32)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Last 7 days (176)
Last 30 days (657)
Last 365 days (10407)
2026 (951)
2025 (10716)
2024 (12502)
2023 (14250)
2022 (19563)
2021 (20082)
2020 (19038)
2019 (14893)
2018 (11717)
2017 (13898)
2016 (13129)
2015 (15473)
2014 (12420)
2013 (10592)
2012 (11395)
2011 (11923)
2010 (10890)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20894)
Australia (2688)
California (3177)
Canada (1481)
China (550)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40885)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (348)
India (44)
Indiana (240)
Iowa (2)
Japan (247)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (421)
Massachusetts (2587)
Michigan (46)
Minnesota (166)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1396)
New Mexico (7)
New York (907)
North Carolina (619)
North Dakota (2)
Northern California (1447)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (716)
Puerto Rico (12)
Rhode Island (17)
South America (509)
South Carolina (10)
Southern California (1387)
Tennessee (53)
Texas (454)
United States (12672)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (224)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
273,869 Results for "iota pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
FDA Grants iota Biosciences IDE Approval for First-In-Human Early Feasibility Study with Implantable Bladder Device
October 10, 2024
·
5 min read
Press Releases
iotaMotion Announces Issuance of U.S. Patent for Robotic-Assisted Cochlear Implantation Technology
June 11, 2025
·
2 min read
Press Releases
Kiniksa Pharmaceuticals Provides Corporate Update
January 12, 2026
·
11 min read
BioForest
Aurion Biotech Announces IOTA Cell Therapy Trial
Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, announced preliminary findings from its IOTA trial, conducted in November 2020 and in May of this year, at the Clínica Quesada in San Salvador, El Salvador.
July 25, 2021
·
5 min read
Press Releases
Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 6, 2026
·
1 min read
Press Releases
Kye Pharmaceuticals Announces Licensing and Distribution Agreement with Neurim Pharmaceuticals for SLENYTO® in Canada
January 13, 2026
·
5 min read
Sponsored
Best Pharmaceutical Label Manufacturers: Reviews and Comparisons
Selecting the ideal pharmaceutical label manufacturer requires careful consideration. This article compares leading companies, highlighting their strengths in regulatory compliance, material performance, serialization, innovation, and sustainability, to help you make an informed decision for your product’s safety and success.
October 27, 2025
·
6 min read
Press Releases
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
February 2, 2026
·
4 min read
Press Releases
Breckenridge Pharmaceutical announces strategic collaboration with Medichem
February 5, 2026
·
3 min read
Business
iotaSciences Appoints Dr. Michael Lutz as New Chief Executive Officer
iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions announced the appointment of Dr. Michael Lutz as CEO and Director for Iota Sciences Ltd.
August 3, 2023
·
3 min read
1 of 27,387
Next
